Home / Market News / $STIM

$STIM news and market catalysts

The 16 most recent market catalysts affecting $STIM, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

16 catalysts 2 high impact 7 bullish 1 bearish Healthcare
Nov 16, 2026 Corporate Catalyst Neutral Impact 55
Neuronetics Insider Sells $4.48 Million in Company Stock
A Neuronetics insider has sold $4.48 million in company stock, as disclosed in a recent SEC 8-K filing. This insider selling event is often perceived negatively by the market, as i…
Nov 11, 2026 Corporate Catalyst Neutral Impact 75
Neuronetics Announces Pricing of $30 Million Underwritten Public Offering
Neuronetics has priced a public offering of 18,750,000 shares at $1.60 per share, aiming to raise $30 million. This move is significant because it will dilute existing shareholders…
Nov 7, 2026 Corporate Catalyst Bullish Impact 55
B. Riley Adjusts Price Target on Neuronetics to $6 From $5, Keeps Buy Rating
Investment firm B. Riley has updated its outlook on Neuronetics, Inc., raising its price target from $5 to $6 and reiterating a 'Buy' rating. This decision comes after Neuronetics'…
Nov 4, 2026 Corporate Catalyst Bullish Impact 75
Neuronetics, Inc. Reports Third Quarter 2026 Financial Results
Neuronetics, Inc. disclosed its third-quarter 2026 financial results, showing a 12.5% year-over-year revenue increase to $42.0 million and positive adjusted EBITDA of $1.9 million.…
Sep 17, 2026 Corporate Catalyst Neutral Impact 55
BTIG Reiterates Buy on Neuronetics, Maintains $6 Price Target
BTIG analyst Sam Eiber reiterated a 'Buy' rating and maintained a $6 price target for Neuronetics (STIM). This action signals continued analyst confidence in the company's future p…
Sep 11, 2026 Corporate Catalyst Neutral Impact 65
B. Riley Securities Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5
B. Riley Securities analyst Madison El-Saadi initiated coverage on Neuronetics (STIM) with a 'Buy' rating and a $5 price target. This event is significant for Neuronetics as new an…
Sep 9, 2026 Corporate Catalyst Neutral Impact 55
BTIG Reiterates Buy on Neuronetics, Maintains $6 Price Target
BTIG analyst Sam Eiber reiterated a 'Buy' rating and maintained a $6 price target for Neuronetics (STIM). This action signals continued analyst confidence in the company's financia…
Aug 11, 2026 Market Technicals Bullish Impact 55
BTIG Maintains Buy on Neuronetics, Raises Price Target to $6
BTIG analyst Sam Eiber has raised the price target for Neuronetics (STIM) from $5 to $6 while maintaining a 'Buy' rating. This action signals continued confidence in the company's …
Aug 11, 2026 Corporate Catalyst Bullish Impact 55
12 Health Care Stocks Moving In Tuesday's Intraday Session
This filing details the intraday performance of twelve healthcare stocks, with six experiencing substantial gains and six significant losses. The primary catalyst for these movemen…
Aug 11, 2026 Corporate Catalyst Bullish Impact 75
Neuronetics shares are trading higher after the company reported better-than-expected Q2 financial results.
This headline directly impacts Neuronetics (STIM) as it signals strong operational performance and financial health, likely leading to increased investor interest and a higher stoc…
Aug 11, 2026 Corporate Catalyst Bearish Impact 75
Neuronetics Narrows FY2026 Sales Guidance from $160.000M-$166.000M to $160.000M-$164.000M vs $161.125M Est
Neuronetics (STIM) has updated its financial outlook for FY2026, lowering the top end of its sales guidance from $166 million to $164 million, while maintaining the lower end at $1…
Aug 11, 2026 Corporate Catalyst Bullish Impact 92
Neuronetics Q2 EPS $(0.05) Beats $(0.13) Estimate, Sales $41.568M Beat $40.175M Estimate
Neuronetics (STIM) announced its Q2 financial results, reporting a loss of $(0.05) per share, significantly better than the analyst consensus of $(0.13). Sales also exceeded expect…
Jul 20, 2026 Corporate Catalyst Neutral Impact 55
Neuronetics Appoints Nir Naor CFO, Effective July 23,
Neuronetics, Inc. has appointed Nir Naor as its new Chief Financial Officer, with an effective date of July 23, 2026. This is a standard executive personnel change within a company…
Jul 20, 2026 Corporate Catalyst Neutral Impact 85
Why Is Neuronetics Stock Soaring Monday?
Neuronetics (STIM) experienced a significant stock surge due to BTIG initiating coverage with a 'Buy' rating and a $5 price target. The core of this positive outlook is STIM's stra…
Jul 20, 2026 Corporate Catalyst Bullish Impact 75
Neuronetics shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and announced a $5 price target.
The initiation of coverage by a reputable firm like BTIG with a 'Buy' rating and a specific price target acts as a strong positive catalyst for Neuronetics. This signals to the mar…
Jul 20, 2026 Corporate Catalyst Neutral Impact 65
BTIG Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5
BTIG analyst Sam Eiber has initiated coverage on Neuronetics (STIM) with a 'Buy' rating and a $5 price target. This event is significant for Neuronetics as new analyst coverage, es…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.